Brazilian valuation of EQ-5D-3L health states

Medical Decision Making

Volumn 36, Issue 2, 2016, Pages 253-263

  Santos, Marisa ^a   Cintra, Monica A C T ^a   Monteiro, Andrea L ^a   Santos, Braulio ^a   Gusmão Filho, Fernando ^b   Andrade, Mônica Viegas ^c   Noronha, Kenya ^c   Cruz, Luciane N ^d   Camey, Suzi ^d   Tura, Bernardo ^a,d   Kind, Paul ^e  

^a INSTITUTO NACIONAL DE CARDIOLOGIA   (Brazil)

^b INSTITUTO DE MEDICINA INTEGRAL PROF FERNANDO FIGUEIRA   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^e UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

EQ 5D; outcomes research; preference weights; quality adjusted life years; social value set; time tradeoff (TTO); value set

Indexed keywords

ADULT; ANXIETY; BRAZIL; BRAZILIAN; FEMALE; GENDER; HEALTH CARE POLICY; HEALTH STATUS; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MODEL; POPULATION; RESOURCE ALLOCATION; STATISTICAL MODEL; ADOLESCENT; AGE; CLINICAL TRIAL; DAILY LIFE ACTIVITY; MENTAL HEALTH; MIDDLE AGED; MULTICENTER STUDY; PAIN; QUALITY OF LIFE; QUESTIONNAIRE; SEX DIFFERENCE; SOCIOECONOMICS; STANDARDS; TIME FACTOR; WALKING DIFFICULTY; YOUNG ADULT;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGE FACTORS; BRAZIL; FEMALE; HEALTH STATUS; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; MOBILITY LIMITATION; PAIN; QUALITY OF LIFE; SEX FACTORS; SOCIOECONOMIC FACTORS; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; YOUNG ADULT;

EID: 84952909836     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X15613521     Document Type: Article

References (34)

1. Kind P, Brooks R, Rabin R., EQ-5D Concepts and Methods: A Developmental History. New York: Springer; 2006.
2. Brooks R., EuroQol: the current state of play. Health Policy. 1996; 37 (1): 53-72.
3. Rabin R, Oemar M, Oppe M., EQ-5D-3L User Guide Basic Information on How to Use the EQ-5D-3L Instrument. Rotterdam: EuroQol Group; 2011.
4. Vianna C, Caetano R, Ugá M., Diretrizes metodológicas para estudos de avaliação econômica de tecnologias em saúde. Brasília: Ministério da Saúde; 2009.
5. Badia X, Roset M, Herdman M, Kind P., A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making. 2001; 21 (1): 7-16.
6. Knies S, Evers S, Candel M, Severens J, Ament A., Utilities of the EQ-5D: transferable or not? Pharmacoeconomics. 2009; 27 (9): 767-779.
7. Williams A., The Measurement and Valuation of Health: A Chronicle: York(UK): University of York.; 1995.
8. Kind P, Dolan P, Gudex C, Williams A., Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ. 1998; 316 (7133): 736-741.
9. Dolan P., Modeling valuations for EuroQol health states. Med Care. 1997; 35 (11): 1095-1108.
10. Augustovski F, Irazola V, Velazquez A, Gibbons L, Craig B., Argentine valuation of the EQ-5D health states. Value Health. 2009; 12 (4): 587-596.
11. Zarate V, Kind P, Chuang LH., Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans. Value Health. 2008; 11 (7): 1170-1177.
12. Dolan P., Modeling valuations for EuroQol health states. Med Care. 1997; 35 (11): 1095-1108.
13. Xie F, Gaebel K, Perampaladas K, Doble B, Pullenayegum E., Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklist. Med Decis Making. 2014; 34 (1): 8-20.
14. Kind P, Macran S, Hennessy S,. Measuring social preferences for EQ-5D health states: results from a saturation study. In: Prevolnik Rupel V, ed. Proceedings of the 20th Plenary Meeting of the EuroQol Group. Bled, Slovenia: Institute of Public Health of the Republic of Slovenia; 2003; 153-162.
15. Busschbach J, McDonnell J, van Hout BA,. Testing different parametric relations between the EuroQol health description and health valuation in students. In: Nord E, ed. EuroQol Plenary Meeting, Oslo 17-18 October 1996. Conference Proceedings. Working paper No 2/97. National Institute of Public Health, Oslo, Norway, 1997.
16. Weinstein MC, Torrance G, McGuire A., QALYs: the basics. Value Health. 2009; 12 (S1): S5-S9.
17. Viegas Andrade M, Noronha K, Kind P, et al. Societal preferences for EQ-5D health states from a Brazilian population survey. Value Health Reg Issues. 2013; 2 (3): 405-412.
18. IBGE. Instituto Brasileiro de Geografia e Estatística 2014 [cited 5 June 2014]. Available from: URL: http://www.ibge.gov.br/home/.
19. Chuang L, Kind P., The effect of health state selection on the valuation of EQ-5D. Med Decis Making. 2011; 31 (1): 186-94.
20. Kind P. A., A Revised Protocol for the Valuation of Health States Defined by the EQ-5D-3L Classification System: Learning the Lessons from the MVH Study. New York: Centre for Health Economics, University of York; 2009.
21. Torrance GW, Thomas WH, Sackett DL., A utility maximization model for evaluation of health care programs. Health Serv Res. 1972; 7 (2): 118.
22. Torrance GW,. Social preferences for health states: an empirical evaluation of three measurement techniques. Socio-economic Planning Sciences. 1976; 10 (3): 129-36.
23. Gudex C., Time Trade-off User Manual: Props and Self-Completion Methods. Report of the Centre for Health Economics, University of York; 1994.
24. Associação Brasileira de Empresas de Pesquisa (ABEP). Critéio de Classificação Econômica Brasil (CCEB). [cited 13 November 2014]. Available from: URL: http://www.abep.org/criterioBrasil.aspx.
25. Shaw JW, Johnson JA, Coons SJ., US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005; 43 (3): 203-20.
26. Tsuchiya A, Ikeda S, Ikegami N, et al. Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002; 11 (4): 341-53.
27. Chevalier J, de Pouvourville G., Valuing EQ-5D using time trade-off in France. Eur J Health Econ. 2013; 14 (1): 57-66.
28. Krabbe PF, Stalmeier PF, Lamers LM, Busschbach JJ., Testing the interval-level measurement property of multi-item visual analogue scales. Qual Life Res. 2006; 15 (10): 1651-61.
29. Rowen D, Brazier J, Roberts J., Mapping SF-36 onto the EQ-5D index: how reliable is the relationship. Health Qual Life Outcomes. 2009; 7: 27.
30. Parkin D, Feng Y, Devlin N, eds. What Determines the shape of an EQ-5D Index Distribution. Health Economics Study Group meeting, Exeter University, 2013.
31. Engel L, Bansback N, Bryan S, Doyle-Waters M, Whitehurst D., Exclusion criteria in national health state valuation studies: a systematic review. Poster presented at: The 36th Annual Meeting of the Society for Medical Decision Making; 18-22 October 2014; Miami, FL.
32. Fagundes SD, Silva MT, Thees MFRS, Pereira MG., Prevalence of dementia among elderly Brazilians: a systematic review. Sao Paulo Med J. 2011; 129 (1): 46-50.
33. Dolan P., Effect of age on health state valuations. J Health Serv Res Policy. 2000; 5 (1): 17-21.
34. Dolan P, Roberts J., To what extent can we explain time trade-off values from other information about respondents?. Soc Sci Med. 2002; 54 (6): 919-29.